ValiRx Management
Management criteria checks 3/4
ValiRx's CEO is Suzy Dilly, appointed in Jun 2020, has a tenure of 4.08 years. total yearly compensation is £162.59K, comprised of 89.2% salary and 10.8% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth €15.50K. The average tenure of the management team and the board of directors is 4.1 years and 1.5 years respectively.
Key information
Suzy Dilly
Chief executive officer
UK£162.6k
Total compensation
CEO salary percentage | 89.2% |
CEO tenure | 4.1yrs |
CEO ownership | 0.3% |
Management average tenure | 4.1yrs |
Board average tenure | 1.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | UK£163k | UK£145k | -UK£2m |
Sep 30 2023 | n/a | n/a | -UK£2m |
Jun 30 2023 | n/a | n/a | -UK£2m |
Mar 31 2023 | n/a | n/a | -UK£2m |
Dec 31 2022 | UK£163k | UK£126k | -UK£2m |
Sep 30 2022 | n/a | n/a | -UK£2m |
Jun 30 2022 | n/a | n/a | -UK£2m |
Mar 31 2022 | n/a | n/a | -UK£2m |
Dec 31 2021 | UK£159k | UK£120k | -UK£2m |
Sep 30 2021 | n/a | n/a | -UK£1m |
Jun 30 2021 | n/a | n/a | -UK£1m |
Mar 31 2021 | n/a | n/a | -UK£1m |
Dec 31 2020 | UK£38k | UK£20k | -UK£1m |
Compensation vs Market: Suzy's total compensation ($USD206.28K) is below average for companies of similar size in the German market ($USD533.87K).
Compensation vs Earnings: Suzy's compensation has been consistent with company performance over the past year.
CEO
Suzy Dilly (46 yo)
4.1yrs
Tenure
UK£162,585
Compensation
Dr. Suzanne J. Dilly, B.Sc., Ph D., also known as Suzy, serves as Director and Chief Executive Officer at ValiRx plc since June 08, 2020. Dr. Dilly has been an employee of ValiRx Group since April 2014 whe...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.1yrs | UK£162.59k | 0.31% £ 14.8k | |
CFO, Company Secretary & Executive Director | no data | UK£69.11k | 0.097% £ 4.6k | |
Head of Operations | 16.5yrs | no data | no data | |
Chief Scientific Officer & Board Observer | 1.8yrs | no data | no data | |
Corporate Development Manager | no data | no data | no data | |
Head of Strategic Commercial Development | no data | no data | no data |
4.1yrs
Average Tenure
Experienced Management: EAJF's management team is considered experienced (4.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | 4.1yrs | UK£162.59k | 0.31% £ 14.8k | |
CFO, Company Secretary & Executive Director | 18.2yrs | UK£69.11k | 0.097% £ 4.6k | |
Chief Scientific Officer & Board Observer | 1.5yrs | no data | no data | |
Member of Commercial Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific & Commercial Advisory Board | no data | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 4.2yrs | UK£28.75k | 0.11% £ 5.1k | |
Board observer | less than a year | no data | no data | |
Independent Non-Executive Director | less than a year | no data | no data |
1.5yrs
Average Tenure
56yo
Average Age
Experienced Board: EAJF's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.